Recombinant Mouse IL-18BP Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01883P-100UG

Mouse IL-18BP on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse IL-18BP Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01883P-100UG
Collections: All products, High-quality recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse IL-18BP Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Thr29-Ala193. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9Z0M9 |
Target Symbol | IL-18BP |
Synonyms | IL-18BP; Igifbp |
Species | Mouse |
Expression System | HEK293 |
Tag | C-hFc |
Expression Range | Thr29-Ala193 |
Mol. Weight | The protein has a predicted MW of 44.7 kDa. Due to glycosylation, the protein migrates to 60-75 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Mouse IL-18BP, hFc Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human IL-18, No Tag with the EC50 of 8.2ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. |